Department of Surgery, Division of Otolaryngology-Head and Neck Surgery, Dartmouth-Hitchcock Medical Center, Lebanon.
Laryngoscope. 2014 Mar;124(3):688-94. doi: 10.1002/lary.24357. Epub 2013 Oct 4.
OBJECTIVES/HYPOTHESIS: Historically, histologic grade has not been considered a useful prognostic factor in head and neck squamous cell carcinoma (SCC). However, in other solid tumors, grade is known to affect prognosis. We test the hypothesis that histologic grade is an independent predictor of prognosis in oral cavity SCC.
Population-based cohort study using the Surveillance, Epidemiology, and End Results (SEER) database of the National Cancer Institute.
Fifteen year cause-specific survival. Multivariate analysis was performed on a subset of patients diagnosed between 2004 and 2008.
Among patients 20 to 65 years of age with American Joint Committee on Cancer (AJCC) stage I or II cancer, the adjusted risk of death is 2.7 times greater (95% CI 1.72-4.11) if the tumor is poorly differentiated or undifferentiated than it is if the tumor is well differentiated. Among patients 66 to 94 years of age, the risk of death is 3.0 (95% CI 2.02-4.54) times greater. For those over age 65, moderately differentiated tumors also confer an estimated 42% increased risk of death, but this estimate is only borderline significant (P = 0.05).
There is a strong association between histologic grade and survival in patients with AJCC stage I or II oral cavity SCC. High histologic grade in early stage oral cavity cancer is associated with poorer survival and carries independent prognostic value in addition to tumor size, node status, and presence of distant metastasis (TNM) stage. Thus, histologic grade should be considered clinically when making treatment decisions, and multivariable models of survival should include grade as a covariate to improve prognostic accuracy.
目的/假设:历史上,组织学分级在头颈部鳞状细胞癌(SCC)中并不被认为是一个有用的预后因素。然而,在其他实体肿瘤中,分级已知会影响预后。我们检验了这样一个假设,即组织学分级是口腔 SCC 预后的一个独立预测因子。
利用美国国立癌症研究所的监测、流行病学和最终结果(SEER)数据库进行基于人群的队列研究。
15 年的特异性生存。对 2004 年至 2008 年间确诊的部分患者进行多变量分析。
在年龄在 20 至 65 岁、AJCC 分期为 I 期或 II 期的患者中,如果肿瘤分化差或未分化,其死亡风险调整后是高分化肿瘤的 2.7 倍(95%CI 1.72-4.11)。对于 66 至 94 岁的患者,死亡风险为 3.0(95%CI 2.02-4.54)倍。对于年龄超过 65 岁的患者,中度分化肿瘤也估计会增加 42%的死亡风险,但这一估计仅具有边缘显著性(P=0.05)。
在 AJCC 分期为 I 期或 II 期的口腔 SCC 患者中,组织学分级与生存之间存在很强的关联。早期口腔癌的高组织学分级与生存较差相关,除了肿瘤大小、淋巴结状态和远处转移(TNM)分期外,还具有独立的预后价值。因此,在制定治疗决策时,临床应考虑组织学分级,并且生存的多变量模型应将分级作为协变量纳入,以提高预后准确性。